Why is Astec Lifescienc falling/rising?

As of 27-Jun, Astec Lifesciences Ltd is currently priced at 943.00, reflecting a decrease of 43.0 points or 4.36%. The stock has recently experienced a trend reversal, falling after five consecutive days of gains. Today, it underperformed its sector by 5.6%, reaching an intraday low of Rs 923, which represents a decline of 6.39%. Despite this drop, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Positive factors include rising promoter confidence, with a 4.12% increase in their stake, indicating belief in the company's future. However, the stock's long-term fundamentals are weak, with a significant decline in operating profits and negative results reported for the last four quarters, contributing to its recent price movement.
In the broader market context, Astec Lifesciences has shown a strong short-term performance, with a 24.62% increase over the past week, compared to a modest 2.00% rise in the Sensex. However, its year-to-date performance is negative at -6.17%, contrasting with the Sensex's positive return of 7.58%. The stock has consistently underperformed against the benchmark over the last three years, which may contribute to investor sentiment and the current price decline. Overall, while there are some positive indicators, the significant long-term challenges and recent negative performance have led to the stock's current downward movement.